AGENDA AT A GLANCE

Day 1
11 March 2026
Leadership Panel: Is Asia Ready to Lead the AI Biopharma Revolution?
Regional Strengths, Challenges & Leadership Pathways
Intelligent Discovery & Molecular Design
AI-enabled Discovery, Predictive Modelling & Next-Gen Biologics
Morning Break – Exhibition Viewing & 1-1 Networking
Digital Biomanufacturing & Process Innovation
Smart Bioprocessing, Automation & Digital Twins
Lunch – Exhibition Viewing & 1-1 Networking
Data-Driven Quality, Compliance & Regulatory Excellence
Digital Validation, Intelligent QA & Global Alignment
Afternoon Break – Exhibition Viewing & 1-1 Networking
Ethics, Governance & Trust in the Digital Era
Transparency, Cybersecurity & Responsible Innovation
End of Conference

Day 1

11 March 2026

Leadership Panel: Is Asia Ready to Lead the AI Biopharma Revolution?

Regional Strengths, Challenges & Leadership Pathways

8:50

Chairman Opening Remarks

9:00

Panel Discussion: Is Asia Ready to Lead the AI Biopharma Revolution?

  • Assessing Asia’s readiness for AI integration across the biopharma value chain.
  • Unlocking innovation through AI-driven discovery and development.
  • Transforming manufacturing with data intelligence and digital twins.
  • Strengthening regulatory harmonisation and ethical governance.
  • Building collaboration networks and future-ready talent across the region.

9:50

Reserved for IDBS

Intelligent Discovery & Molecular Design

AI-enabled Discovery, Predictive Modelling & Next-Gen Biologics

10:15

Accelerating Drug Discovery through Multimodal Data Integration

  • Integrating omics, imaging, and clinical data to create unified AI models for drug discovery.
  • Strengthening target identification, drug efficacy predictions, and patient stratification.
  • Overcoming data silos to enable a more efficient and predictive discovery pipeline.

10:40

Morning Break – Exhibition Viewing & 1-1 Networking

Digital Biomanufacturing & Process Innovation

Smart Bioprocessing, Automation & Digital Twins

11:00

Optimising Cell Culture Media through Digital Tools and Real-Time Feedback

  • AI-based optimisation of cell culture media for improved consistency and yield.
  • Real-time monitoring and adaptive feedback to fine-tune production parameters.
  • Predicting process outcomes and improving reproducibility across production cycles.

11:25

Reserved for Solution Provider

Andreas Schaaf | Managing Director / CSO, Eleva, Germany

11:50

Achieving Global Manufacturing Control with Unified Dashboards

  • Connecting MES, LIMS, and SCADA to centralised platforms.
  • Predictive monitoring for bottlenecks, deviations, and failures.
  • Achieving real-time control across global production environments.

12:15

Lunch – Exhibition Viewing & 1-1 Networking

Data-Driven Quality, Compliance & Regulatory Excellence

Digital Validation, Intelligent QA & Global Alignment

2:00

Enhancing Quality Control with Predictive Insights and Automated Risk Management

  • Leveraging AI-driven quality monitoring for early detection of deviations and risks.
  • Automating root cause analysis (RCA) and corrective actions (CAPA) to ensure compliance.
  • Strengthening data integrity and reducing regulatory risks through continuous monitoring.

2:25

Reserved for Solution Providers

2:50

Leveraging AI and Digital Tools for Regulatory Success Across the Biopharma Value Chain

  • Enhancing regulatory submission accuracy with AI-driven data analysis and automated documentation.
  • Streamlining compliance monitoring through digital tools that integrate R&D, manufacturing, and distribution.
  • Improving audit readiness and data integrity by automating risk management processes with AI.

3:15

Afternoon Break – Exhibition Viewing & 1-1 Networking

Ethics, Governance & Trust in the Digital Era

Transparency, Cybersecurity & Responsible Innovation

4:00

Building Responsible AI Frameworks for Biopharma

  • Defining ethical guidelines and governance for AI use.
  • Building audit trails and explainable decision-making processes.
  • Aligning AI development with regulatory and ethical standards.

4:25

Reserved for Solution Providers

4:50

Securing AI-Driven Biopharma Systems and Protecting Intellectual Property

  • Implementing robust cybersecurity measures to protect AI models and data integrity.
  • Securing sensitive training data and ensuring AI system transparency.
  • Protecting intellectual property and ensuring compliance with global security standards.

5:15

Chairman Closing Remarks

5:20

End of Conference - Day 1

5:20

Cocktails & Networking

6:00

ABEA Awards 2026


Want to Speak at This Event?

Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.

Apply to Speak

For Speaking Opportunities, Kindly Contact:

Abishek Manoharan, Conference Producer

[email protected]

+65 6371 9705

Get Your Ticket
View the 2025 Post-Event Report